Its payday!
Recent BIAF News
- bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 • Business Wire • 05/12/2026 01:15:00 PM
- bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung • Business Wire • 05/08/2026 12:30:00 PM
- bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment • Business Wire • 04/28/2026 01:16:00 PM
- New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy • Business Wire • 04/14/2026 12:00:00 PM
- bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 • Business Wire • 04/07/2026 12:00:00 PM
- bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 • Business Wire • 04/01/2026 12:00:00 PM
- BioAffinity shares rise as CyPath Lung growth boosts optimism • IH Market News • 03/25/2026 03:02:01 PM
- bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice • Business Wire • 03/25/2026 12:00:00 PM
- New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures • Business Wire • 03/17/2026 11:45:00 AM
- bioAffinity Technologies Posts 2025 Results as CyPath Lung Testing Growth Accelerates • IH Market News • 03/13/2026 03:31:25 PM
- bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung • Business Wire • 03/13/2026 12:00:00 PM
- bioAffinity Launches Large-Scale Clinical Study for Lung Cancer Detection Technology • IH Market News • 03/10/2026 02:39:38 PM
- bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic • Business Wire • 03/10/2026 11:47:00 AM
- bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients • Business Wire • 03/03/2026 01:30:00 PM
- bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test • Business Wire • 02/25/2026 01:30:00 PM
- New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer • Business Wire • 02/19/2026 04:00:00 PM
- Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study • Business Wire • 02/17/2026 01:00:00 PM
- bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board • Business Wire • 02/09/2026 01:00:00 PM
- bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation • Business Wire • 01/07/2026 01:00:00 PM
- bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable • Business Wire • 12/03/2025 01:00:00 PM
- bioAffinity Technologies Reports Third Quarter 2025 Financial Results • Business Wire • 11/14/2025 01:00:00 PM
- bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume • Business Wire • 11/05/2025 01:00:00 PM
- bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases • Business Wire • 10/28/2025 12:00:00 PM
- bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025 • Business Wire • 10/20/2025 12:00:00 PM
- bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer • Business Wire • 10/16/2025 12:00:00 PM
